Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ubiquinol in Parkinson's Disease
NCT03061513Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of coenzyme q10 in Parkinson's disease (PD), sponsored by Weill Cornell Medicine. Started Feb 2012; status: completed.
02
Drugs
coenzyme q10
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03061513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061513.